RxDoctor Payments Data

Vetri Sudar Jayaprakasam

Nuclear Medicine · New York, NYNPI 1871137828

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $907 of the $1,404 with a category attached, or 64.6%. Every reported general payment came from a single manufacturer, Novartis.

$1,404in general payments, 2019–2025

Across 5 payments — averaging $280.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1K
$342,063in research payments, 2019–2025

Across 4 payments — averaging $85,516 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$342K

What the payments were for

  • Travel & lodging$90765%
  • Food & beverage$49635%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis5$1,404

How this compares

$1,404 in reported general payments places this provider in the 75th percentile of 84 nuclear medicine providers in New York.

See all nuclear medicine providers in New York

Medicare billing

Part B allowed, 2024
$94,858
Medicare patients
780
Services billed
834

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nuclear medicine in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →